DEF 14A: Beneficient Seeks Stockholder Approval for Share Issuance to Yorkville Under Standby Equity Purchase Agreement

Beneficient is asking stockholders to approve the issuance of Class A common stock to YA II PN, LTD. (Yorkville) under a Standby Equity Purchase Agreement (SEPA) to comply with Nasdaq Listing Rule 5635(d).

Summary

• Beneficient is holding a Special Meeting of Stockholders on June 20, 2024, to vote on two proposals.
• The first proposal seeks approval for the issuance of Class A common stock to Yorkville under a Standby Equity Purchase Agreement (SEPA), as required by Nasdaq Listing Rule 5635(d).
• The shares issued to Yorkville may represent more than 20% of the company's outstanding common stock.
• The second proposal requests approval to adjourn the Special Meeting if there are insufficient votes to approve the Yorkville Share Issuance Proposal.
• The Board recommends voting FOR both the Yorkville Share Issuance Proposal and the Adjournment Proposal.
• The record date for determining stockholders eligible to vote is May 24, 2024.
• The company effected a reverse stock split of its Common Stock at a ratio of eighty (80) to one (1) on April 18, 2024.
• From June 27, 2023 through the close of business on May 24, 2024, the Company issued 398,125 shares of Class A Common Stock pursuant to the SEPA for a total of approximately $3.4 million.
• Additionally, the Company issued 5,703 shares of Class A Common Stock to Yorkville in payment of a commitment fee pursuant to the terms of the SEPA.

Sentiment

Score: 6

Explanation: The document is primarily informational, outlining proposals for a stockholder vote. While the company highlights the benefits of the SEPA, there are also acknowledged risks associated with dilution and potential limitations on capital raising if the proposal is not approved.

Positives

• The SEPA with Yorkville provides Beneficient with a reliable source of capital for general corporate purposes.
• The SEPA offers future flexibility to enhance the company's liquidity in an opportunistic and efficient manner.
• The Board believes that the ability to issue shares under the SEPA is in the best interests of the company and its stockholders.

Negatives

• Approval of the share issuance will dilute the percentage ownership interest of current stockholders.
• The issuance of shares could dilute the book value per share of the Class A Common Stock.
• An increase in the number of outstanding shares could cause the market price of the Class A Common Stock to decrease.
• Failure to approve the proposal could limit the company's ability to raise additional capital under the SEPA.

Risks

• If the Yorkville Share Issuance Proposal is not approved, the company may need to seek alternative sources of capital, which may not be available on favorable terms or at all.
• The company may have difficulty entering into liquidity transactions if it is unable to raise additional capital, which could lead to a decrease in revenues.
• Depressed trading prices of the Class A Common Stock could further impair the company's ability to raise sufficient capital from operations.
• The company cannot predict the price of its Common Stock at any future date, and therefore cannot predict the number of shares of Class A Common Stock to be issued under the SEPA or whether the applicable price for any Advance Notice will be greater than the minimum price under the Nasdaq Rules.

Future Outlook

The company expects that the directors and executive officers will vote all their shares in favor of each of the Yorkville Share Issuance Proposal and the Adjournment Proposal.

Management Comments

• Our Board has determined that the SEPA and our ability to issue the shares of Class A Common Stock thereunder in excess of the Exchange Cap are in the best interests of the Company and its stockholders because the ability to sell shares of Class A Common Stock to Yorkville provides us with a reliable source of capital for general corporate purposes, which may include, but are not limited to, funding working capital, capital expenditures, operating expenses and the selective pursuit of business development opportunities.
• Furthermore, the SEPA provides the Company with future flexibility to enhance its liquidity in an opportunistic and efficient manner.

Industry Context

The need for stockholder approval for share issuances is governed by Nasdaq Listing Rules, which aim to protect shareholder interests by preventing excessive dilution and ensuring fair pricing in transactions.

Comparison to Industry Standards

• Standby Equity Purchase Agreements (SEPAs) are relatively common financing tools for publicly traded companies, particularly smaller-cap companies seeking flexible access to capital.
• The terms of Beneficient's SEPA, including the discount to market price and volume limitations, are generally consistent with industry standards for similar agreements.
• Other companies that have utilized SEPAs include those in the biotechnology, technology, and energy sectors.

Stakeholder Impact

• Approval of the share issuance will dilute the ownership interest of existing stockholders.
• The company's ability to raise capital and execute its strategic plans could be affected depending on the outcome of the vote.
• Employees, customers, suppliers, and creditors could be indirectly impacted by the company's financial stability and ability to operate effectively.

Next Steps

• Stockholders are urged to review the Proxy Statement and vote on the proposals.
• The Special Meeting will be held on June 20, 2024, to vote on the Yorkville Share Issuance Proposal and the Adjournment Proposal.
• The Company expects to publish the voting results of the Special Meeting in a Current Report on Form 8-K, which it expects to file with the SEC within four business days following the date of the Special Meeting.

Key Dates

Keywords

Yorkville, SEPA, share issuance, Nasdaq Listing Rule 5635(d), proxy statement, Beneficient, stockholder approval, Class A Common Stock, capital, dilution